Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

methylphenidate

methylphenidate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Aptensio XR, Cotempla XR-ODT, Metadate CD, Quillichew ER, Ritalin LA    
Metadate ER, Methylin, Methylin (chewable), Ritalin    
methylphenidate ER 24 hr CAPSULE, EXTENDED RELEASE, ORAL 10 mg, 20 mg, 30 mg      
Jornay PM CAPSULE, EXTENDED RELEASE, ORAL 20 mg, 40 mg, 60 mg, 80 mg, 100 mg    
Adhansia XR CAPSULE, EXTENDED RELEASE, ORAL 25 mg, 35 mg, 45 mg, 55 mg, 70 mg, 85 mg    
Daytrana FILM, EXTENDED RELEASE, TRANSDERMAL 10 mg, 15 mg, 20 mg, 30 mg      
Quillivant XR SUSPENSION, EXTENDED RELEASE, ORAL 5 mg/mL      
methylphenidate ER 8hr TABLET, EXTENDED RELEASE, ORAL 10 mg      
Concerta TABLET, EXTENDED RELEASE, ORAL 18 mg, 27 mg      
Concerta TABLET, EXTENDED RELEASE, ORAL 36 mg, 54 mg    
methylphenidate IR TABLET, ORAL 5 mg, 10 mg      
Comments:

Methylphenidate LA-ER and CD-ER capsules are considered therapeutically equivalent.  Dispense/stock the most cost effective product.

Methylphenidate CD-ER (10 mg, 20 mg, 30 mg) are currently the preferred formulation [August 2019].

 

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

methylphenidate (Aptensio XR)

  • 10 mg ER capsule
  • 15 mg ER capsule
  • 20 mg ER capsule
  • 30 mg ER capsule
  • 40 mg ER capsule                  
  • 50 mg ER capsule                                                        
  • 60 mg ER capsule

methylphenidate CD-ER capsule 24hr

  • 10 mg ER capsule
  • 10 mg ER capsule
  • 20 mg ER capsule
  • 30 mg ER capsule
  • TWO 20 mg ER capsules (Total: 40 mg)
  • ONE 30 mg ER capsule PLUS ONE 20 mg ER capsule (Total: 50 mg)
  • TWO 30 mg ER capsules (Total: 60 mg)

 

 

methylphenidate (Cotempla XR-ODT)

  • 8.6 mg XR ODT
  • 17.3 mg XR ODT
  • 25.9 mg XR ODT

methylphenidate CD-ER capsule 24hr

  • 10 mg ER capsule
  • 20 mg ER capsule
  • 30 mg ER capsule

Cotempla XR-ODT has same bioavailability as methylphenidate ER 24 hour formulations. Methylphenidate ER caps may be opened and sprinkled onto applesauce if necessary.

methylphenidate (Metadate CD)

  • 10 mg ER capsule
  • 20 mg ER capsule
  • 30 mg ER capsule

methylphenidate CD-ER capsule 24hr

  • 10 mg ER capsule
  • 20 mg ER capsule
  • 30 mg ER capsule

 

methylphenidate ER (QuilliChew ER)

  • 10 mg ER chewable tablet
  • 15 mg ER chewable tablet
  • 20 mg ER chewable tablet
  • 30 mg ER chewable tablet
  • 40 mg ER chewable tablet
  • 60 mg ER chewable tablet

methylphenidate CD-ER capsule 24hr

  • 10 mg ER capsule
  • 10 mg ER capsule
  • 20 mg ER capsule
  • 30 mg ER capsule
  • TWO 20 mg ER capsules (Total: 40 mg)
  • TWO 30 mg ER capsules (Total: 60 mg)

Methylphenidate ER caps may be opened and sprinkled onto applesauce if necessary.

methylphenidate (Ritalin LA)

  • 20 mg ER capsule
  • 30 mg ER capsule
  • 40 mg ER capsule                                

methylphenidate CD-ER capsule 24hr

  • 20 mg ER capsule
  • 30 mg ER capsule
  • TWO 20 mg ER capsules (Total: 40 mg)

 

methylphenidate (Metadate ER)

  • 10 mg ER tablet
  • 20 mg ER tablet                               

methylphenidate ER tablet 8hr

  • 10 mg ER tablet
  • TWO 10 mg ER tablets (Total: 20 mg)

 

methylphenidate ER tablet

  • 20 mg ER tablet                              
  • 30 mg ER tablet                                                      

methylphenidate ER tablet 8hr

  • TWO 10 mg ER tablets (Total: 20 mg)
  • THREE 10 mg ER tablets (Total: 30 mg)

 

methylphenidate (Methylin)

  • 5 mg tablet
  • 10 mg tablet
  • 20 mg tablet                                                     

methylphenidate IR tablet

  • 5 mg tablet
  • 10 mg tablet
  • TWO 10 mg tablets (Total: 20 mg)

 

methylphenidate (Methylin chew)

  • 2.5 mg chewable tablet
  • 5 mg chewable tablet
  • 10 mg chewable tablet

methylphenidate IR tablet

  • HALF 5 mg tablet (Total: 2.5 mg)
  • 5 mg tablet
  • 10 mg tablet
 Methylphenidate IR tabs may be crushed and sprinkled onto applesauce if necessary.

methylphenidate (Ritalin)

  • 5 mg tablet
  • 10 mg tablet
  • 20 mg tablet                                                     

methylphenidate IR tablet

  • 5 mg tablet
  • 10 mg tablet
  • TWO 10 mg tablets (Total: 20 mg)

 

methylphenidate hydrochloride (Adhansia XR)

  • 25 mg
  • 35 mg 
  • 45 mg
  • 55 mg
  • 70 mg
  • 85 mg

methylphenidate ER capsule 24 hr

  • 20 mg
  • 30 mg
  • 40 mg (20 mg x 2 capsules)
  • 50 mg (20 mg + 30 mg capsule)
  • 60 mg (30 mg x 2 capsules)
  • 80 mg (two 30 mg + one 20 mg capsule)

 

methylphenidate (Jornay PM ER)

  • 20 mg qHS
  • 40 mg qHS
  • 60 mg qHS
  • 80 mg qHS
  • 100 mg qHS

methylphenidate ER capsule 24 hr

  • 20 mg qAM
  • 20 mg x 2 capsules qAM
  • 30 mg x 2 capsules qAM
  • 20 mg x 4 capsules qAM
  • 30 mg x 3 capsules + 10 mg qAM

 

 

Concerta medication guide
Daytrana medication guide
Metadate CD medicaiton guide
Methylin chewable tablet medication guide
Methylin oral solution medication guide
QuilliChew ER medication guide
Quillivant XR medication guide
Ritalin medication guide
Ritalin LA medication guide
Ritalin-SR medication guide

Daytrana (methylphenidate patch) is approved for formulary if a patient already on the patch needs to continue therapy in the hospital and doesn't have their own. Initiation should be deferred to the outpatient setting, and if possible the patient should use their home medication for inpatient use. If this is not possible, a small number of patches may be ordered.

 

QUILLAVANT XR is classified as non-formulary, not stocked. Contact the prescriber to switch to an alternative methylphenidate product; or if necessary, the patient may use his/her own supply during admission.

 

Jornay PM ER is non-formulary, not stocked. Therapeutic interchange from Jornay PM ER oral capsule to methylphenidate ER (24 hour) oral capsules. Evaluate to determine if patient received Jornay-PM the night prior to starting inpatient methylphenidate ER product.

 

Reviewed: July 25, 2006 (DAYTRANA), and March 26, 2013 (Quillivant XR), and 17 Nov 2015 (Aptensio XR), and 26 July 2016 (QuilliChew ER), and 24 Oct 2017 (Cotempla XR), and 26 June 19 (Formulary Update), December 2019 (Adhansia XR & Jornay PM ER)

Last updated: Dec. 20, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved